Dana Investment Advisors, Inc.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1427514 BROOKFIELD, WI

Position in MDGL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,673,533

+$4,547 QoQ

Shares Held

3,197

+11.5% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 94.99530810134502.ToString("F0")% Shared 0.ToString("F0")% None 5.00469189865499.ToString("F0")%

Healthcare · as of Mar 31, 2026

Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. MDGL ranks #5 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	69,234	$13,822,568
2	REGN	Regeneron Pharmaceuticals, Inc.	8,397	$6,487,858
3	AXSM	Axsome Therapeutics, Inc.	26,379	$4,458,578
4	VKTX	Viking Therapeutics, Inc.	59,756	$1,944,460
5	MDGL	Madrigal Pharmaceuticals, Inc. This page	3,197	$1,673,533
6	TGTX	Tg Therapeutics, Inc.	43,954	$1,460,151
7	ZYME	Zymeworks Inc.	56,107	$1,404,919
8	IONS	Ionis Pharmaceuticals Inc	18,487	$1,388,188

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,673,533	3,197	+11.5%	Shares	Sole	2026-05-14
2025-12-31	$1,668,986	2,866	-9.9%	Shares	Sole	2026-02-05
2025-09-30	$1,458,997	3,181	+10.3%	Shares	Sole	2025-11-10
2025-06-30	$872,511	2,883	-2.4%	Shares	Sole	2025-08-13
2025-03-31	$978,122	2,953	-28.9%	Shares	Sole	2025-05-15
2024-12-31	$1,280,874	4,151	+15.8%	Shares	Sole	2025-02-06
2024-09-30	$760,596	3,584	-3.5%	Shares	Sole	2024-11-13
2024-06-30	$1,040,234	3,713	+13.4%	Shares	Sole	2024-08-27
2024-03-31	$874,556	3,275	+3.3%	Shares	Sole	2024-05-15
2023-12-31	$733,705	3,171	+4.1%	Shares	Sole	2024-02-07
2023-09-30	$444,983	3,047	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.